IS FECAL CALPROTECTIN USEFUL IN THE FOLLOW-UP OF CROHN’S DISEASE PATIENTS WITH ANTI-TNF THERAPY ?

(1) University of Oradea

(2) "Victor Babes" University



This item was part of the IBD II session at UEG Week 2013

This item can be cited as: United European Gastroenterology Journal; 2013: 1 (Supplement 1) A367

You may be interested in:

PHARMACOLOGY OF ETROLIZUMAB IN A PHASE 2 STUDY IN MODERATE TO SEVERELY ACTIVE ULCERATIVE COLITIS
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
HYPOXIS HEMEROCALLIDEA CORM AMELIORATES ACUTE EXPERIMENTAL COLITIS
English, Aetiology / Causes, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013
EFFICACY OF INFLIXIMAB IN PAEDIATRIC ULCERATIVE COLITIS: SINGLE TERTIARY CENTRE EXPERIENCE
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013

Categorisation:

  • Clinical Specialty
    • 'IBD-ology'
  • Disease
    • Inflammatory bowel disease
  • Disease Feature
    • Clinical aspects
  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2013